BDI Pharma, Inc. Continues Growth Regardless of Market Volatility

COLUMBIA, SC--(Marketwire - August 10, 2009) - BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that sales for the first two quarters of 2009 represented a sixteen percent (16%) increase in comparison to the same time period in 2008. Record sales were posted by BDI in the critical business classes of specialty biopharmaceuticals, vaccines and plasma biotherapeutics.

"Our company's flexibility to adapt and expand its distribution in times of market flux has always been a differentiating factor for BDI Pharma," said Richard J. Gaton, Co-President. "Whether in a constricted market or one like we are experiencing now, with over-supply of specific product lines, BDI has continued to grow because of the breadth of value which we offer as both a committed supplier to this country's healthcare providers and as a loyal trade partner to many of the world's most sophisticated manufacturers."

About BDI Pharma, Inc.

Serving the healthcare community since 1995, BDI Pharma, Inc. has built an outstanding reputation as an industry source for products and service. BDI Pharma's market focus is evident in its commitment to specialty biotherapeutics, chemotherapies, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a manufacturer recognized Authorized Distributor of Record, BDI Pharma, Inc. services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI Pharma, Inc. defines its customer-centric approach to serving the nation's healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI Pharma, Inc.'s educational literature and Web site -- www.bdipharma.com -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.